Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.

Eligibility criteria

Qualifiers

Adults ≥18 years of age

Able to speak and read English

Diagnosed with a meningioma

Disqualifiers

Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)

Inability to consent secondary to severe neurologic deficit or psychiatric distress

Inability to complete survey secondary to severe neurologic deficit or psychiatric distress

Trial design

Treatments tested in this trial

  • Questionnaire
  • Medical Record Review

Treatment groups

3,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Cancer Institute (NCI)

Collaborator